HJ
Hitesh Jayantilal Vagadia
About Hitesh Jayantilal Vagadia
Data last updated:
Hitesh Jayantilal Vagadia was a Cfo at Calyx Chemicals And Pharmaceuticals Limited (2015–2016), Additional Director at Lysca Pharmaceuticals Private Limited (2021) and Additional Director at Unived Healthcare Products Private Limited (2019–2020). The companies operate in Pharma and E-Commerce.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Calyx Chemicals And Pharmaceuticals Limited U24220MH1986PLC038618 | Cfo | 01 Apr 2015 | 1986 | ₹164 Cr (FY 2024) | Active |
 Lysca Pharmaceuticals Private Limited U24230MH2020PTC339574 | Additional Director | 09 Aug 2021 | 2020 | ₹1.08 Cr (FY 2024) | Active |
 Unived Healthcare Products Private Limited U24297MH2012PTC237326 | Additional Director | 11 Dec 2019 | 2012 | ₹12.89 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hitesh Jayantilal Vagadia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hitesh Jayantilal Vagadia
Hitesh Jayantilal Vagadia was first appointed on 01 Apr 2015 as Cfo at Calyx Chemicals And Pharmaceuticals Limited. The most recent appointment on record is 09 Aug 2021 at Lysca Pharmaceuticals Private Limited.
Hitesh Jayantilal Vagadia held 3 earlier board appointments: Calyx Chemicals And Pharmaceuticals Limited (Cfo, 01 Apr 2015 to 31 Dec 2016); Lysca Pharmaceuticals Private Limited (Additional Director, 09 Aug 2021 to 24 Dec 2021); Unived Healthcare Products Private Limited (Additional Director, 11 Dec 2019 to 05 Oct 2020).